CHPA names health policy director
The Consumer Healthcare Products Association is growing its ranks with the addition of a director of health policy. Marina Karp has been named to the newly created role, tasked with helping develop CHPA’s health policy priorities and engage stakeholders regarding the value of OTCs, dietary supplements and consumer medical devices, the organization said.
“We are thrilled to welcome Marina with her unique skills to the team,” said David Spangler, CHPA’s senior vice president of policy and general counsel. “Health policy issues of concern to consumers – and healthcare systems – including access to safe and affordable medicines, effective symptom relief and prevention, and the demand for self-care options are where consumer healthcare products provide tremendous value. This new position at CHPA will enable us to better quantify and communicate that value to the wider U.S. healthcare sector.”
Before joining CHPA in June, Karp was director of research for healthcare research and policy analysis firm Keckler Group. She also previously was associate director of research for the Navigant Center for Healthcare Research and Policy Analysis. Her policy briefs and white papers have focused on the impact of legislative and regulatory changes on the healthcare delivery system.
No comments found